Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer's Perspective

Author： Duran Aurea  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.2, 2012-02, pp. : 87-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fondaparinux versus enoxaparin for the prevention of venous thromboembolism

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 455-457

Informa Healthcare

Access to resources Recommend Favorite

Dermatan Sulfate versus Unfractionated Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Surgery for Cancer: A Cost-Effectiveness Analysis

By Attanasio E.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 57-68

Adis International

Access to resources Recommend Favorite

Enoxaparin: In the Prevention of Venous Thromboembolism in Medical Patients

By Warner G.T.   Perry C.M.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 477-481

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients: Modelling Study from the Hospital Perspective in Germany

By Schädlich Peter K.  

PharmacoEconomics, Vol. 24, Iss. 6, 2006-01 ,pp. : 571-591

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in Poland: Modelling Study from the Hospital Perspective

By Orlewska E.  

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 737-748

Adis International

Access to resources Recommend Favorite